Dysregulation of the inflammatory response by Francisella tularensis

土拉弗朗西斯菌引起的炎症反应失调

基本信息

  • 批准号:
    10228332
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

Tularemia is a potentially fatal disease and the causative agent, Francisella tularensis (Ft), is one of few bacterial pathogens that can infect both neutrophils (polymorphonuclear leukocytes, PMNs) and macrophages. Notably, macrophages and neutrophils appear to play distinctly different roles in tularemia pathogenesis, with macrophages acting as major vehicles for bacterial growth and dissemination, and PMNs playing a central role in host tissue destruction. Neutrophils are short lived, and unlike other leukocytes are preprogrammed to undergo apoptosis 24 h after release into the circulation. Tight spatial and temporal control of this process is critical for elimination of infection and resolution of inflammation, and for this reason defects in PMN turnover exemplify a dysregulated and ineffective inflammatory response that promotes tissue destruction and disease. In keeping with this, we discovered that Ft inhibits human neutrophil apoptosis and markedly prolongs cell lifespan, and demonstrated that this is achieved via effects on the intrinsic and extrinsic apoptosis pathways, as well as changes in the neutrophil transcriptome that include significant differential expression of 365 unique genes linked to apoptosis and cell fate. Nevertheless, how cell lifespan is prolonged is only partially understood. Herein, we propose groundbreaking studies based on our discovery of neutrophil metabolic reprogramming as a new mechanism for apoptosis inhibition. Our proposed studies are supported by extensive preliminary data, and are highly innovative, as integrated manipulation of glycolysis and organelle function has not been previously documented as a mechanism for regulation of PMN lifespan during infection. Potential effects of these changes on bacterial growth and the influence of PMN metabolites on macrophage polarization will also be determined. In addition, we recently identified bacterial lipoproteins (BLPs) as active factors in Ft conditioned medium (CM) that extend PMN lifespan via a mechanism that is dependent on a common single nucleotide polymorphism (SNP) in human TLR1 (rs5743618, T1805G) that significantly influences the severity and lethality of sepsis as well as the outcomes of many infectious and inflammatory diseases, including but not limited to tuberculosis, pyelonephritis, atherosclerosis, arthritis, lupus, colitis, and cancer. Elucidating the mechanism(s) of BLP and TLR2/1-driven apoptosis inhibition is a second objective of this study. Our experimental design will also utilize drugs that specifically target HIF-1 and TLR2, mitophagy, glycolysis or other relevant signaling intermediates to identify points for therapeutic intervention that are expected to be relevant to many diseases that affect Veterans. Our specific aims are: 1) To elucidate the mechanisms and functional consequences of neutrophil metabolic reprogramming. 2) To elucidate the mechanisms of BLP and TLR2/1-mediated apoptosis inhibition and potential for theraputic intervention.
土拉菌病是一种潜在的致命疾病,其病原体土拉菌(Ft)是少数病原体之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lee-Ann H Allen其他文献

Lee-Ann H Allen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lee-Ann H Allen', 18)}}的其他基金

Neutrophil Plasticity and H. pylori Pathogenesis
中性粒细胞可塑性和幽门螺杆菌发病机制
  • 批准号:
    10243858
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
ShEEP Request for Zeiss LSM880 Confocal Microscope
ShEEP 请求蔡司 LSM880 共焦显微镜
  • 批准号:
    9210692
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Neutrophil Plasticity and H. pylori Pathogenesis
中性粒细胞可塑性和幽门螺杆菌发病机制
  • 批准号:
    9109153
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    8668724
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    8538674
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
2013 Phagocytes Gordon Research Conference and Seminar
2013年吞噬细胞戈登研究会议暨研讨会
  • 批准号:
    8521619
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    10426024
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    9898231
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    10620249
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Dysregulation of the inflammatory response by Francisella tularensis
土拉弗朗西斯菌引起的炎症反应失调
  • 批准号:
    8803366
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
  • 批准号:
    82371140
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
多孔Ti-MSNs@MGF+DX抗炎—成肌体系应用于颞下颌关节假体的作用和机制研究
  • 批准号:
    82370984
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
  • 批准号:
    82371691
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
  • 批准号:
    82372120
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
  • 批准号:
    31970688
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
炎症因子调控干眼病眼表黏蛋白表达的分子机制
  • 批准号:
    81100636
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
TRAM基因选择性调控LPS失控性炎症反应的实验研究
  • 批准号:
    81071588
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目

相似海外基金

Dysregulation of inflammation resolution as therapeutic target for IBD
炎症消退失调作为 IBD 的治疗靶点
  • 批准号:
    10663586
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Dysregulation of Epithelial Metabolism and Regeneration by Sulfite Exposure in Pediatric Ulcerative Colitis
小儿溃疡性结肠炎亚硫酸盐暴露导致上皮代谢和再生失调
  • 批准号:
    10722914
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Genetic Variants of Immune Dysregulation and Thrombotic Microangiopathy in Severe Pediatric Sepsis Induced Organ Dysfunction
严重小儿脓毒症引起的器官功能障碍中免疫失调和血栓性微血管病的遗传变异
  • 批准号:
    10571065
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Investigating mechanisms of oxidized phospholipid-mediated dysregulation of regulatory T cells in atherosclerosis
研究动脉粥样硬化中氧化磷脂介导的调节性 T 细胞失调的机制
  • 批准号:
    10648711
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
ADRD spousal caregivers, loneliness, & immune dysregulation: Real-Time, real-world intervention targets
ADRD 配偶照顾者、孤独、
  • 批准号:
    10651524
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea
红斑痤疮局部和全身免疫失调的多组学研究
  • 批准号:
    10590784
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer’s disease
基于 MicroRNA 脂质纳米颗粒的疗法针对阿尔茨海默病中的神经炎症和 ApoE 失调
  • 批准号:
    10667157
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Fibroblast dysregulation promotes dermal eosinophilic/Th2 inflammation
成纤维细胞失调促进真皮嗜酸性/Th2炎症
  • 批准号:
    10725870
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease
阿尔茨海默病转录失调的分子遗传学分析
  • 批准号:
    10467106
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Platelets in radiation-induced immune dysregulation
辐射引起的免疫失调中的血小板
  • 批准号:
    10474901
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了